Tag Archives: $100M

Arranta Bio splashes $100M into ‘microbiome’ CDMO capacity with new Massachusetts facility

With the microbiome market set to expand to more than $ 1 billion in the coming years, contract manufacturers across the board are putting big down payments on capacity for live therapies that target gut bacteria. Now, a fledgling CDMO is splurging to make its name in that blossoming field. Microbiome CDMO firm Arranta Bio has completed… Read More »